Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunoglobulin A: magic bullet or Trojan horse?
Heineke MH, van Egmond M. Heineke MH, et al. Among authors: van egmond m. Eur J Clin Invest. 2017 Feb;47(2):184-192. doi: 10.1111/eci.12716. Epub 2017 Jan 19. Eur J Clin Invest. 2017. PMID: 28024097 Review.
Monoclonal antibody-mediated killing of tumour cells by neutrophils.
Heemskerk N, van Egmond M. Heemskerk N, et al. Among authors: van egmond m. Eur J Clin Invest. 2018 Nov;48 Suppl 2(Suppl Suppl 2):e12962. doi: 10.1111/eci.12962. Epub 2018 Jul 5. Eur J Clin Invest. 2018. PMID: 29855035 Free PMC article. Review.
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
Treffers LW, van Houdt M, Bruggeman CW, Heineke MH, Zhao XW, van der Heijden J, Nagelkerke SQ, Verkuijlen PJJH, Geissler J, Lissenberg-Thunnissen S, Valerius T, Peipp M, Franke K, van Bruggen R, Kuijpers TW, van Egmond M, Vidarsson G, Matlung HL, van den Berg TK. Treffers LW, et al. Among authors: van houdt m, van den berg tk, van bruggen r, van egmond m, van der heijden j. Front Immunol. 2019 Jan 30;9:3124. doi: 10.3389/fimmu.2018.03124. eCollection 2018. Front Immunol. 2019. PMID: 30761158 Free PMC article.
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity.
Heemskerk N, Gruijs M, Temming AR, Heineke MH, Gout DY, Hellingman T, Tuk CW, Winter PJ, Lissenberg-Thunnissen S, Bentlage AE, de Donatis M, Bögels M, Rösner T, Valerius T, Bakema JE, Vidarsson G, van Egmond M. Heemskerk N, et al. Among authors: van egmond m. J Clin Invest. 2021 Mar 15;131(6):e134680. doi: 10.1172/JCI134680. J Clin Invest. 2021. PMID: 33561014 Free PMC article.
NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models.
Gruijs M, Ganzevles SH, Stigter-van Walsum M, van der Mast R, van Ostaijen-Ten Dam MM, Tuk CW, Schilham MW, Leemans CR, Brakenhoff RH, van Egmond M, van de Ven R, Bakema JE. Gruijs M, et al. Among authors: van der mast r, van de ven r, van ostaijen ten dam mm, van egmond m. Int J Mol Sci. 2021 Oct 14;22(20):11057. doi: 10.3390/ijms222011057. Int J Mol Sci. 2021. PMID: 34681717 Free PMC article.
216 results